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The MexAB-OprM efflux pump of Pseudomonas
aeruginosa is central to multidrug resistance of this
organism, which infects immunocompromised hospital
patients. The MexA, MexB, and OprM subunits were as-
sumed to function as the membrane fusion protein, the
body of the transporter, and the outer membrane chan-
nel protein, respectively. For better understanding of
this important xenobiotic transporter, we show the x-
ray crystallographic structure of MexA at a resolution of
2.40 Å. The global MexA structure showed unforeseen
new features with a spiral assembly of six and seven
protomers that were joined together at one end by a
pseudo 2-fold image. The protomer showed a new pro-
tein structure with a tandem arrangement consisting of
at least three domains and presumably one more. The
rod domain had a long hairpin of twisted coiled-coil that
extended to one end. The second domain adjacent to the
rod -helical domain was globular and constructed by a
cluster of eight short -sheets. The third domain located
distal to the -helical rod was globular and composed of
seven short -sheets and one short -helix. The 13-mer
was shaped like a woven rattan cylinder with a large
internal tubular space and widely opened flared ends.
The 6-mer and 7-mer had a funnel-like structure consist-
ing of a tubular rod at one side and a widely opened
flared funnel top at the other side. Based on these re-
sults, we constructed a model of the MexAB-OprM pump
assembly. The three pairs of MexA dimers interacted
with the periplasmic -barrel domain of OprM via the
-helical hairpin, the second domain interacted with
both MexB and OprM at their contact site, and the third
and disordered domains probably interacted with the
distal domain of MexB. In this fashion, the MexA subunit
connected MexB and OprM, indicating that MexA is the
membrane bridge protein.
Emergence of infectious agents resistant to structurally and
functionally dissimilar chemotherapeutic agents is increas-
ingly problematic in human health. An important factor con-
tributing to this multidrug resistance is the drug or xenobiotic
efflux pump, which lowers the intracellular drug concentration
by exporting incoming chemotherapeutic agent across the
membranes. Pseudomonas aeruginosa easily infects immuno-
compromised hospital patients, and this low virulent bacte-
rium often is life-threatening. A problem associated with
P. aeruginosa infection is that this organism shows a broad
spectrum of intrinsic and mutational resistances to structur-
ally and functionally dissimilar antibiotics (1–6). These mul-
tiantibiotic resistances in this organism are largely attributa-
ble to the expression of multidrug efflux pumps (7, 8). The
P. aeruginosa chromosome encodes several drug exporter
genes, and among them, MexAB-OprM is central to both
intrinsic and mutational multidrug resistance.
The resistance nodulation division (RND)1 family efflux
pump, including MexAB-OprM, consists of three membrane
bound subunits, such as MexA, MexB, and OprM, anchoring
the inner and outer membranes, respectively (4, 5, 9–11). The
MexB subunit is central to the pump function, which spans the
cytoplasmic membrane 12 times, selects antibiotics to be ex-
ported, and is assumed to transport the substrates expending
the energy of the proton gradient across the cytoplasmic mem-
brane (12–14). The crystal structure of an MexB homologue,
AcrB of Escherichia coli, showed that the protein consisted
mainly of three domains: the membrane spanning domain, the
pore domain, and the TolC docking domain (15).
The OprM subunit is the outer membrane-anchored lipopro-
tein that is assumed to play a role in the final step of antibiotic
extrusion facilitating the exit of antibiotic across the outer
membrane (5, 16, 17). Structural analysis of the OprM homo-
logue, TolC of E. coli, revealed that the trimeric assemblies of
the protomer consisted largely of two domains: an outer mem-
brane spanning the -barrel and a long -helical barrel ex-
tended to the periplasmic space (18).
The MexA subunit anchors an inner membrane via fatty
acid(s) attached to the N-terminal cysteine residue (5, 16, 19,
20). Presence of the membrane fusion protein is indispensable
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in xenobiotic export by the RND family proteins (1, 21, 22).
Deletion of the fatty acyl moiety liberates the protein from the
membrane, and the protein became freely soluble in aqueous
solutions. This mutant protein had a fully functional antibiotic
efflux (19) and, therefore, it was assumed that the entire pro-
tein moiety of MexA protruded to the periplasmic aqueous
space. The MexA subunit and its homologue proteins were,
therefore, assumed to connect the inner and outer membrane
subunits and hence designated as the membrane fusion protein
(MFP) (16). However, the precise structure and function of the
MFPs remain to be clarified. For better understanding of the
MFPs, we analyzed the x-ray crystal structure of MexA of
P. aeruginosa, and here we report its structure.
EXPERIMENTAL PROCEDURES
Bacterial Cell, Culture Conditions, and Cell Fractionation—The
bacterial strain used was P. aeruginosa TNP070 lacking chromo-
somal mexA (21). The pAzu-MexA plasmid was a derivative of
pMMB67EH/HE carrying the Azu-MexA-(His)6 fusion gene as de-
scribed previously (19). TNP070 was transformed with pAzu-MexA, and
this was used throughout this study. Cells were grown in L-broth at
37 °C with shaking at 220 rpm to A600
1.0 cm  0.7. Isopropyl-1-thio--D-
galactoside was added to the concentration of 0.5 mM and shaken as
above for an additional 2.5 h. The cells were harvested by centrifugation
at 24 °C, suspended in a buffer containing 50 mM Tris-HCl, pH 7.2, 0.2
mM MgCl2, and a tablet of the protease inhibitor mixture (Roche Ap-
plied Science, Complete Mix) and subjected to cold-shock treatment by
alternatively immersing the cell suspension in water baths at 37 and
0 °C three times (17). The cell suspension was centrifuged at 10,000 
g for 10 min at 4 °C, and the supernatant fraction was centrifuged again
at 150,000  g for 60 min at 4 °C. The soluble fraction was retained for
further treatment.
Purification of the MexA-(His)6—The cold-shock material from 1 liter
of culture was mixed with a 2-ml packed volume of nickel-nitrilotriace-
tic acid-Sepharose resin (Invitrogen, ProBond) and gently stirred at
4 °C for 15 min. The resin suspension was packed into an open column,
washed with 20 ml of the washing buffer containing 50 mM sodium
phosphate, pH 7.2, 0.3 M NaCl, and 20 mM imidazole. Next, the column
was eluted with a buffer containing 50 mM sodium phosphate, pH 7.2,
0.3 M NaCl, 250 mM imidazole. The yield of homogeneously purified
MexA was consistently 6–7 mg/liter of culture. Purified MexA was
subjected to dialysis against a large excess of 20 mM HEPES, pH 7.2, 0.3
M LiCl, 80 mM imidazole overnight with several changes of dialysis
buffer. The protein concentration was adjusted to 10 mg/ml using the
Vivaspin concentrator (VivaScience).
Crystallization—The hanging-top vapor diffusion technique was
used throughout this study. Five parts of MexA (10 mg/ml) in the
dialysis buffer was mixed with 4 parts of the reservoir buffer containing
60 mM HEPES, pH 7.2, 40 mM Tris-HCl, pH 7.2, 10% of glycerol, 3% of
2-methyl-2,4-pentandiol, and 26–28% polyethylene glycol 1000 and one
part of the additive (50% Jeffamine-M600, pH 7.0, Hampton Research).
The setup mixture was kept at 20 °C in an incubator for 1–2 weeks. The
rod-shaped MexA crystals grew to the size of about 0.7 0.5 0.3 mm3.
The space group was P21 with cell dimensions of a  130.0 Å, b  180.3
Å, c  214.2 Å,   107.0°.
Diffraction Data Collection—Diffraction data for structure determi-
nation were collected at beamlines of the synchrotron facilities of Pho-
ton Factory (Ibaraki, Japan) and SPring-8 (Hyogo, Japan). Diffraction
data of native MexA were collected on the DIP6040 imaging plate/CCD
hybrid detector (MacScience, Bruker-AXS) at BL44XU at SPring-8 (Na-
tive 1) and on the Quantum 4R CCD detector (Area Detector System
Corp.) at BL6A at the Photon Factory (Native 2). Diffraction data of the
Lu derivative, which was prepared by soaking in 2 mM Lu(O2C2H5)2 for
2 h, were collected on the Quantum 210 CCD detector (Area Detector
System Corp.) at AR-NW12 at the Photon Factory. The diffraction
images were reduced, scaled, and merged with the HKL2000 package
(23). The intensities were then converted to the structure factor ampli-
tudes with TRUNCATE in CCP4 (24). Summary of crystallographic
data and refinement statistics are given in Table I in the supplemental
material.
Structure Determination—The single isomorphous replacement with
the anomalous scattering (SIRAS) method using the Lu derivative was
applied to solve the crystallographic phase problem. Native 2 data were
used as a native data set for phase determination. Initially six Lu sites
were located using SHELX-97 (25). Heavy atom parameter refinement
and SIRAS phasing were carried out using the program SHARP (26).
Minor sites of heavy atoms were found subsequently in residual maps
after the refinement of heavy atom parameters by SHARP, and finally
14 Lu sites were included for phase calculation. Phase improvement
using the density modification technique with SOLOMON (27) and DM
(28) integrated in SHARP was applied. The atomic model was built
using program O (29) and refined against the native 1 data set. At the
initial stage of refinement, a simulated-annealed torsion angle refine-
ment using CNS (30) was applied. Subsequent cycles of manual revision
of the atomic model using program O and restrained-parameter maxi-
mum-likelihood refinement carried out by REFMAC5 (31) in CCP4 (24)
were conducted to refine the atomic structure.
RESULTS AND DISCUSSION
Structural Analysis—The SIRAS method using the
Lu(O2C2H5)2 was applied using SHARP (26). The atomic model
was built using program O (29) and then refined using CNS
(30) and refmac5 (31). Details of structure analysis were given
in the section of supplemental materials.
Overall Structure of the Monomer—At the current stage of
refinement, 68.3% of the residues were visible. N- and C-ter-
minal residues provided little structural information. The best
ordered monomer structure shows 252 residues (from 23 to
274) among 369 amino acid residues of Azu-MexA-(His)6. The
FIG. 1. Two-dimensional topology models of MexA. The two-
dimensional model was constructed on the basis of the x-ray crystallo-
graphic data and the DSSP program (42). Localization of -helices and
-sheets was arbitrary and that of each domain was simplified to ease
understanding of the relative position. Columns and arrows indicate
-helices (magenta) and -sheets (cyan).
FIG. 2. Stereo view of the MexA monomer. Ribbon model of the
MexA monomer: gradient rainbow color of blue to red indicates N- to
C-terminal.
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overall structure showed that the MexA monomer consisted
mainly of three domains and possibly one additional unseen
domain due to a disorder as follows (Figs. 1 and 2). (i) At one
end, two -helices (from Ala74 to Ala102 and from Lys108 to
Arg133) formed a long left-hand twisted -helical hairpin struc-
ture designated as the -domain. (ii) The globular domain
adjacent to the -helical domain consisted of eight short
-sheets designated as the -domain. This domain shows a
topology similar to the biotinyl/lipoyl carrier proteins and do-
mains family was defined in the SCOP data base (32). (iii)
Another globular domain adjacent to the central -domain,
distal to the -domain, was composed of seven short -strands
and one short -helix designated as the -domain. (iv) The
poorly solved disordered domain contained the N- and C-ter-
minal regions (Fig. 1). There was a turn of about 60° against
the -helix hairpin at the loops between the -domain and the
-domain forming a sickle shape (Fig. 2). The topological ar-
rangement of - and -domains agreed well with the predicted
model (33).
Overall Structure of the Tridecamer (13-mer)—The crystal
structure of MexA appeared as a spiral assembly of the 13
protomer by contiguous joining of the hexamer and heptamer
forming a rod at the middle and a funnel-top structure at both
ends (Fig. 3A). The 13-mer had an internal space with widely
opened ends. The hexamer and heptamer were spirally as-
sembled with a side-by-side contiguity of each monomer so that
the spiral structure continued until the first molecule touched
the seventh molecule at the narrower end, but the wider part of
the first and last molecules remained untouched exhibiting a
large unsealed lateral side (Fig. 3, B and C). At the end of the
heptamer, the orientation of the protomer was inverted, and
the spiral assembly of the hexamer continued along one end of
the heptamer. The structure of the hexamer and heptamer may
be divided into two parts; one domain is a tightly packed barrel
structure with anti-parallel arranged -helices and another is a
widely opened petal-like structure mainly formed by two (or
more) globular domains mostly composed of the -barrel
structure.
Assembly Model of the MexAB-OprM Efflux Pump—As we
constructed the MexA model, it was of great interest to fit this
newly obtained MexA structure to that of the MexB and OprM
subunits and envisages the structure of the whole transporter
assembly. One may ask whether or not MexA, MexB, and
OprM interact each other. We examined interaction of MexB
and OprM with tagged MexA and found by the immunoblotting
method that non-tagged MexB and OprM were copurified with
tagged MexA suggesting that these three subunits are in com-
plex in vivo.2 Since the three-dimensional structures of MexB
and OprM is not yet available, they were simulated by amino
acid replacement of the MexB and OprM instead of their ho-
mologues, AcrB and TolC of E. coli, respectively, and molecular
models were constructed.
At first, it was necessary to determine the orientation of the
MexA structure. Since MexA was mainly located in the inner
membrane fraction (19), and the N-terminal end of MexA was
fatty acid-modified, it is highly likely that at least one end of
MexA anchored the inner membrane (19). Since the N- and
2 E. Mokhonova, V. Mokhonov, and T. Nakae, manuscript in
preparation.
FIG. 3. Ribbon diagrams of a representative MexA structure.
A, stereo side view of the structure of the tridecamer. Heptamer and
hexamer are colored red and blue, respectively. B, bottom view of Fig.
1A (hexamer). Each monomer is distinguished by alternatively chang-
ing the color to blue and gray, respectively. C, top view of Fig. 1A
(heptamer). Each monomer is distinguished by alternatively changing
the color to red and gray, respectively. The figures were drawn by
MolScript version 2.1.2 (40) and Raster 3D version 2.7b (41).
FIG. 4. Fitting model of the MexA
structure to MexB and OprM. MexA,
MexB, and OprM are colored red, pink,
and light sky-blue, respectively. A, the fig-
ure is drawn on the basis of the sleeve
model. The first and twelfth molecules are
distinguished by magenta and blue colors,
respectively. Symbols: a, a side view; b, a
vertical view from the OprM side. B, fig-
ure is based on the 3-fold MexA-dimer
model. Two MexA molecules in the dimer
are distinguished by blue and red colors,
respectively. Symbols: a, a side view; b, a
vertical view from the OprM side.
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C-terminal ends of MexA were located at the disordered do-
main adjacent to the -domain, MexA must be oriented with
the -domain located proximal to MexB and the -domain
directed toward OprM. Lines of evidence support this conclu-
sion. (i) The domain swapping experiments between AcrA of E.
coli and its homologue protein suggested that the C-terminal
proximal region of AcrA is important in the interaction with
AcrB (34). (ii) AcrA was chemically cross-linked with AcrB (35).
The first question to be answered was whether or not the
MexA 13-mer is present in intact cells. Although an approxi-
mate longitudinal size of the 13-mer agreed well with the
distance between the inner and outer membranes (36), we
assume that the 13-mer is most likely a crystallographic arti-
fact by the reasons that MexA is mainly fractionated with the
inner membrane and the -domain is located at both ends of
the 13-mer (Fig. 3A). The next question was whether or not the
spiral assembly of MexAs exists in the cells. The first model we
present is the sleeve model based on the structure of MexA in
which an MexA sleeve holds the distal domains of MexB, and
the -helical domains of MexA interact with OprM (Fig. 4A).
This simple model fitted well with the predicted function of
MexA; however, the interior space of the sleeve appeared to be
too small to accommodate the MexB and OprM junction, and
also the spiral structure of MexA was less compatible with the
flat configuration of MexB and OprM. Yet, it is conceivable that
MexA winds around the MexB-OprM interaction site laterally
(Fig. 4A). We calculated that a total 12 of MexA molecules
might be needed to wind around a MexB-OprM trimer. Thus,
we have not yet discarded this model.
The second model we would like to offer is the 3-fold MexA-
dimer model that interacts with an MexA-OprM trimer (Fig.
4B). This subunit stoichiometry is based on our quantitative
determination in intact cells of the individual subunit that five
to six molecules of MexA are present per trimer of MexB and
OprM (37). Presence of the dimeric MexA was supported by gel
filtration experiments in which a small fraction of MexA was
eluted in the position corresponding to the dimer, although the
majority of MexA appeared to be monomeric in aqueous solu-
tion (data not shown). Fitting of -helices of the MexA dimer
with the lower part of OprM resulted in good helix-helix inter-
action of OprM and MexA with a contact angle of about 20°
(Fig. 4B). This 20°-angle contact of the -helices was supported
by a report that the second most abundant -helix contact was
a 20° angle (38). Thus, it is likely that MexA and OprM interact
by means of the respective -helices. Consequently, the globu-
lar -domain in the middle of the MexA fits with the MexB-
OprM contact region, where a gap was formed. The globular
-domains and disordered domain may have interacted with
the MexB trimer. The disordered region is likely to have inter-
acted with MexB as suggested with AcrA of E. coli (34).
Three models have been proposed for a possible mechanical
role of MFP based on the sequence alignment study (33); a fully
extended MFP directly bridges the inner and outer mem-
branes; the -helical hairpins is located parallel to the mem-
brane domain; a -helical hairpin interacts with the outer
membrane subunits, and the remaining domains anchor to the
inner membrane. Our crystal structure of MexA supports none
of these proposals. The two-dimensional crystals of AcrA were
subjected to electron cryography (39). The 20-Å resolution
model predicted the presence of a central opening with a diam-
eter of about 30 Å, which is in fairly good agreement with the
present result. However, the global structure based on the
two-dimensional crystals was largely different from that eluci-
dated from x-ray crystallography.
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